FilingSEC EDGAR8-K
Zura Bio Completes Enrollment for Key Clinical Trials and Reaffirms Data Readout Timelines
· SEC accepted
StagePhase 2
Filing content
Zura Bio has completed enrollment for its TibuSHIELD and TibuSURE clinical trials, exceeding targets, and remains on track for upcoming topline data readouts.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…